Quercetin administration in diabetic rats also effectively decreases the levels of serum C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), blood glucose, and inflammatory cytokines by enhancing AKT phosphorylation, inhibiting nuclear factor-kappa (NF-κB) levels, and reducing inflammation-induced hyperlipidemia (Hosseini et al., 2021). Here, CRP is linked to hyperlipidemia.